<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
85006-2908-1
</NDCCode>
<PackageDescription>
.05 mL in 1 VIAL, SINGLE-DOSE (85006-2908-1)
</PackageDescription>
<NDC11Code>
85006-2908-01
</NDC11Code>
<ProductNDC>
85006-2908
</ProductNDC>
<ProductTypeName>
HUMAN PRESCRIPTION DRUG
</ProductTypeName>
<ProprietaryName>
Ahzantive
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Aflibercept-mrbb
</NonProprietaryName>
<DosageFormName>
INJECTION, SOLUTION
</DosageFormName>
<RouteName>
INTRAVITREAL
</RouteName>
<StartMarketingDate>
20240601
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
BLA
</MarketingCategoryName>
<ApplicationNumber>
BLA761378
</ApplicationNumber>
<LabelerName>
Valorum Biologics, LLC
</LabelerName>
<SubstanceName>
AFLIBERCEPT-MRBB
</SubstanceName>
<StrengthNumber>
40
</StrengthNumber>
<StrengthUnit>
mg/mL
</StrengthUnit>
<Pharm_Classes>
Vascular Endothelial Growth Factor Inhibitor [EPC], Vascular Endothelial Growth Factor Inhibitors [MoA]
</Pharm_Classes>
<DEASchedule/>
<Status>
Active
</Status>
<LastUpdate>
2025-11-25
</LastUpdate>
<PackageNdcExcludeFlag>
N
</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>
N
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>
20261231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
20251024
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage>
N
</SamplePackage>
</NDC>